中国循证心血管医学杂志
中國循證心血管醫學雜誌
중국순증심혈관의학잡지
CHINESE JOURNAL OF EVIDENCE-BASES CARDIOVASCULAR MEDICINE
2015年
3期
390-393
,共4页
李荣%陈爱文%苏星烽%李少霞%甘敏%陈玉环
李榮%陳愛文%囌星烽%李少霞%甘敏%陳玉環
리영%진애문%소성봉%리소하%감민%진옥배
尿酸%N端脑利钠肽%急性心力衰竭
尿痠%N耑腦利鈉肽%急性心力衰竭
뇨산%N단뇌리납태%급성심력쇠갈
Uric acid%N-terminal pro brain natriuretic peptide%Acute heart failure
目的:探讨联合尿酸和NT-proBNP对急性心力衰竭(AHF)患者短期不良预后的预测价值。方法连续入选2011年10月至2014年1月在高新区人民医院内科住院并诊断为AHF的患者193例,分别测定血尿酸(UA)和N-端脑利钠钛(NT-ProBNP)水平,随访6个月,记录期间发生的心血管事件,定义为心源性死亡和/或因心力衰竭而再住院。结果193例患者中,有23例死亡(11.9%),20例(10.4%)在随访期内因心力衰竭(HF)再住院。单因素回归分析显示,短期心血管不良事件发生的预测因素包括高水平的UA和NT-proBNP、低肾小球滤过率、未使用血管紧张素转换酶抑制剂或血管紧张素受体阻断剂及高龄等。多因素Cox回归分析表明,UA水平与心血管事件的发生率增加独立相关(HR=1.115;95%CI:1.006~1.235;P=0.037)。Kaplan-Meier生存分析显示,UA水平>8.0 mg/dL及NT-ProBNP>4210 pg/mL的患者发生心血管事件的风险最高(P=0.01)。结论对于AHF患者,UA和NT-ProBNP水平联合可作为短期不良预后的独立预测因素,且比其中单用一种标志物更有效。
目的:探討聯閤尿痠和NT-proBNP對急性心力衰竭(AHF)患者短期不良預後的預測價值。方法連續入選2011年10月至2014年1月在高新區人民醫院內科住院併診斷為AHF的患者193例,分彆測定血尿痠(UA)和N-耑腦利鈉鈦(NT-ProBNP)水平,隨訪6箇月,記錄期間髮生的心血管事件,定義為心源性死亡和/或因心力衰竭而再住院。結果193例患者中,有23例死亡(11.9%),20例(10.4%)在隨訪期內因心力衰竭(HF)再住院。單因素迴歸分析顯示,短期心血管不良事件髮生的預測因素包括高水平的UA和NT-proBNP、低腎小毬濾過率、未使用血管緊張素轉換酶抑製劑或血管緊張素受體阻斷劑及高齡等。多因素Cox迴歸分析錶明,UA水平與心血管事件的髮生率增加獨立相關(HR=1.115;95%CI:1.006~1.235;P=0.037)。Kaplan-Meier生存分析顯示,UA水平>8.0 mg/dL及NT-ProBNP>4210 pg/mL的患者髮生心血管事件的風險最高(P=0.01)。結論對于AHF患者,UA和NT-ProBNP水平聯閤可作為短期不良預後的獨立預測因素,且比其中單用一種標誌物更有效。
목적:탐토연합뇨산화NT-proBNP대급성심력쇠갈(AHF)환자단기불량예후적예측개치。방법련속입선2011년10월지2014년1월재고신구인민의원내과주원병진단위AHF적환자193례,분별측정혈뇨산(UA)화N-단뇌리납태(NT-ProBNP)수평,수방6개월,기록기간발생적심혈관사건,정의위심원성사망화/혹인심력쇠갈이재주원。결과193례환자중,유23례사망(11.9%),20례(10.4%)재수방기내인심력쇠갈(HF)재주원。단인소회귀분석현시,단기심혈관불량사건발생적예측인소포괄고수평적UA화NT-proBNP、저신소구려과솔、미사용혈관긴장소전환매억제제혹혈관긴장소수체조단제급고령등。다인소Cox회귀분석표명,UA수평여심혈관사건적발생솔증가독립상관(HR=1.115;95%CI:1.006~1.235;P=0.037)。Kaplan-Meier생존분석현시,UA수평>8.0 mg/dL급NT-ProBNP>4210 pg/mL적환자발생심혈관사건적풍험최고(P=0.01)。결론대우AHF환자,UA화NT-ProBNP수평연합가작위단기불량예후적독립예측인소,차비기중단용일충표지물경유효。
Objective To discuss the predictive value of uric acid (UA) combining N-terminal pro brain natriuretic peptide (NT-proBNP) to short-term poor prognosis in patients with acute heart failure (AHF). Methods AHF patients (n=193) were chosen from Oct. 2011 to Jan. 2014, and their levels of UA and NT-ProBNP were detected and followed up for 6 m. The major adverse cardiovascular events (MACE) and rehospitalized cases due to cardiac death and/or heart failure were recorded. Results Of 193 patients, there were 23 (11.9%) died and 20 (10.4%) rehospitalized due to AHF. Single-factor regression analysis showed that predictive factors of short-term MACE risk included high levels of UA and NT-proBNP, lower glomerular filtration rate, angiotensin converting enzyme inhibitor, angiotensin receptor blocker and elderly age. Multi-factor Cox regression analysis showed that UA level was independently correlated to increase of MACE incidence (HR=1.115;95%CI:1.006~1.235;P=0.037). Kaplan-Meier survival analysis showed that risk of MACE was the highest in patients with UA>8.0 mg/dL and NT-ProBNP>4210 pg/mL (P=0.01). Conclusion UA combining NT-ProBNP can be taken as an independent predictive factor for short-term poor prognosis in AHF patients, which is more effective than any single one of them.